APO Research
Talk to an analyst

APO RESEARCH · REPORT

Embolization Particle

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Selected research

Market Structure

Global Embolization Particle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025186 pages

Choose your research edition.

Industry ResearchEmbolization Particle Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Embolization Particle Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Embolization Particle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Embolization Particle Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Embolization Particle Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

This report provides an overview of the global Embolization Particle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Embolization Particle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Embolization Particle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Embolization Particle market size, projected growth trends, production technologies, key applications, and end-use industries.

Embolization Particle Segment by Company

Sirtex Medical

Merit Medical

Cook Medical

BTG Medical

Boston Scientific Corporation

Terumo Corporation

HENGRUI Medical

INterface BIOmaterials B.V.

Alicon

Embolization Particle Segment by Type

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Embolization Particle Segment by Application

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Others

Embolization Particle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Embolization Particle market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Embolization Particle Industry Trends Table 2. Embolization Particle Industry Drivers Table 3. Embolization Particle Industry Opportunities and Challenges Table 4. Embolization Particle Industry Restraints Table 5. Global Embolization Particle Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Embolization Particle Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Embolization Particle Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Embolization Particle Sales Market Share by Manufacturers Table 9. Global Embolization Particle Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Embolization Particle Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Embolization Particle Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Embolization Particle Manufacturers, Product Type & Application Table 13. Global Embolization Particle Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Embolization Particle by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Microspheres Table 17. Major Manufacturers of Particles (e.g. PVA Particles, Gelfoam Particles) Table 18. Major Manufacturers of Drug-eluting Beads (DEBs) Table 19. Major Manufacturers of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Table 20. Global Embolization Particle Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Embolization Particle Sales by Type (2021-2026) & (K Units) Table 22. Global Embolization Particle Sales by Type (2027-2032) & (K Units) Table 23. Global Embolization Particle Sales Market Share by Type (2021-2026) Table 24. Global Embolization Particle Sales Market Share by Type (2027-2032) Table 25. Global Embolization Particle Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Embolization Particle Revenue by Type (2021-2026) & (K Units) Table 27. Global Embolization Particle Revenue by Type (2027-2032) & (K Units) Table 28. Global Embolization Particle Revenue Market Share by Type (2021-2026) Table 29. Global Embolization Particle Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Uterine Fibroid Embolization Table 31. Major Manufacturers of Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Table 32. Major Manufacturers of Liver Tumor Embolization Table 33. Major Manufacturers of Trauma Embolization Table 34. Major Manufacturers of Others Table 35. Global Embolization Particle Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Embolization Particle Sales by Application (2021-2026) & (K Units) Table 37. Global Embolization Particle Sales by Application (2027-2032) & (K Units) Table 38. Global Embolization Particle Sales Market Share by Application (2021-2026) Table 39. Global Embolization Particle Sales Market Share by Application (2027-2032) Table 40. Global Embolization Particle Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Embolization Particle Revenue by Application (2021-2026) & (K Units) Table 42. Global Embolization Particle Revenue by Application (2027-2032) & (K Units) Table 43. Global Embolization Particle Revenue Market Share by Application (2021-2026) Table 44. Global Embolization Particle Revenue Market Share by Application (2027-2032) Table 45. Global Embolization Particle Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Embolization Particle Sales by Region (2021-2026) & (K Units) Table 47. Global Embolization Particle Sales Market Share by Region (2021-2026) Table 48. Global Embolization Particle Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Embolization Particle Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Embolization Particle Sales by Country (2021-2026) & (K Units) Table 52. North America Embolization Particle Sales by Country (2027-2032) & (K Units) Table 53. Europe Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Embolization Particle Sales by Country (2021-2026) & (K Units) Table 55. Europe Embolization Particle Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Embolization Particle Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Embolization Particle Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Embolization Particle Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Embolization Particle Sales by Country (2027-2032) & (K Units) Table 62. Global Embolization Particle Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Embolization Particle Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Embolization Particle Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Embolization Particle Revenue Market Share by Region (2021-2026) Table 66. Global Embolization Particle Revenue Market Share by Region (2027-2032) Table 67. Sirtex Medical Company Information Table 68. Sirtex Medical Business Overview Table 69. Sirtex Medical Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sirtex Medical Embolization Particle Product Portfolio Table 71. Sirtex Medical Recent Development Table 72. Merit Medical Company Information Table 73. Merit Medical Business Overview Table 74. Merit Medical Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merit Medical Embolization Particle Product Portfolio Table 76. Merit Medical Recent Development Table 77. Cook Medical Company Information Table 78. Cook Medical Business Overview Table 79. Cook Medical Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Cook Medical Embolization Particle Product Portfolio Table 81. Cook Medical Recent Development Table 82. BTG Medical Company Information Table 83. BTG Medical Business Overview Table 84. BTG Medical Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. BTG Medical Embolization Particle Product Portfolio Table 86. BTG Medical Recent Development Table 87. Boston Scientific Corporation Company Information Table 88. Boston Scientific Corporation Business Overview Table 89. Boston Scientific Corporation Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Boston Scientific Corporation Embolization Particle Product Portfolio Table 91. Boston Scientific Corporation Recent Development Table 92. Terumo Corporation Company Information Table 93. Terumo Corporation Business Overview Table 94. Terumo Corporation Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Terumo Corporation Embolization Particle Product Portfolio Table 96. Terumo Corporation Recent Development Table 97. HENGRUI Medical Company Information Table 98. HENGRUI Medical Business Overview Table 99. HENGRUI Medical Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. HENGRUI Medical Embolization Particle Product Portfolio Table 101. HENGRUI Medical Recent Development Table 102. INterface BIOmaterials B.V. Company Information Table 103. INterface BIOmaterials B.V. Business Overview Table 104. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. INterface BIOmaterials B.V. Embolization Particle Product Portfolio Table 106. INterface BIOmaterials B.V. Recent Development Table 107. Alicon Company Information Table 108. Alicon Business Overview Table 109. Alicon Embolization Particle Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Alicon Embolization Particle Product Portfolio Table 111. Alicon Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Embolization Particle Distributors List Table 115. Embolization Particle Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Embolization Particle Product Image Figure 2. Global Embolization Particle Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Embolization Particle Market Size (2021-2032) & (US$ Million) Figure 4. Global Embolization Particle Sales (2021-2032) & (K Units) Figure 5. Global Embolization Particle Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Embolization Particle Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Microspheres Image Figure 9. Particles (e.g. PVA Particles, Gelfoam Particles) Image Figure 10. Drug-eluting Beads (DEBs) Image Figure 11. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Image Figure 12. Global Embolization Particle Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Embolization Particle Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Embolization Particle Sales Market Share by Type (2021-2032) Figure 15. Global Embolization Particle Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Embolization Particle Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Embolization Particle Revenue Market Share by Type (2021-2032) Figure 18. Uterine Fibroid Embolization Image Figure 19. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Image Figure 20. Liver Tumor Embolization Image Figure 21. Trauma Embolization Image Figure 22. Others Image Figure 23. Global Embolization Particle Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Embolization Particle Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Embolization Particle Sales Market Share by Application (2021-2032) Figure 26. Global Embolization Particle Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Embolization Particle Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Embolization Particle Revenue Market Share by Application (2021-2032) Figure 29. North America Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Embolization Particle Sales Market Share by Country (2021-2032) Figure 31. U.S. Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Embolization Particle Sales Market Share by Country (2021-2032) Figure 36. Germany Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Embolization Particle Sales Market Share by Country (2021-2032) Figure 43. China Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Embolization Particle Sales Market Share by Country (2021-2032) Figure 51. Brazil Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Embolization Particle Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Embolization Particle Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Embolization Particle Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Embolization Particle Revenue (2021-2032) & (US$ Million) Figure 62. North America Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Embolization Particle Revenue (2021-2032) & (US$ Million) Figure 64. Europe Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Embolization Particle Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Embolization Particle Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Embolization Particle Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Embolization Particle Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Microspheres
  • Particles (e.g. PVA Particles, Gelfoam Particles)
  • Drug-eluting Beads (DEBs)
  • Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Applications
  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others
Companies covered
  • Sirtex Medical
  • Merit Medical
  • Cook Medical
  • BTG Medical
  • Boston Scientific Corporation
  • Terumo Corporation
  • HENGRUI Medical
  • INterface BIOmaterials B.V.
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Embolization Particle Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Embolization Particle Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Embolization Particle Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Embolization Particle Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Embolization Particle Market Dynamics
  1. 2.1 Embolization Particle Industry Trends
  2. 2.2 Embolization Particle Industry Drivers
  3. 2.3 Embolization Particle Industry Opportunities and Challenges
  4. 2.4 Embolization Particle Industry Restraints
3 Embolization Particle Market by Manufacturers
  1. 3.1 Global Embolization Particle Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Embolization Particle Sales by Manufacturers (2021-2026)
  3. 3.3 Global Embolization Particle Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Embolization Particle Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Embolization Particle Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Embolization Particle Manufacturers, Product Type & Application
  7. 3.7 Global Embolization Particle Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Embolization Particle Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Embolization Particle Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Embolization Particle Tier 1, Tier 2, and Tier 3
4 Embolization Particle Market by Type
  1. 4.1 Embolization Particle Type Introduction
  2. 4.1.1 Microspheres
  3. 4.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)
  4. 4.1.3 Drug-eluting Beads (DEBs)
  5. 4.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
  6. 4.2 Global Embolization Particle Sales by Type
  7. 4.2.1 Global Embolization Particle Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Embolization Particle Sales by Type (2021-2032)
  9. 4.2.3 Global Embolization Particle Sales Market Share by Type (2021-2032)
  10. 4.3 Global Embolization Particle Revenue by Type
  11. 4.3.1 Global Embolization Particle Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Embolization Particle Revenue by Type (2021-2032)
  13. 4.3.3 Global Embolization Particle Revenue Market Share by Type (2021-2032)
5 Embolization Particle Market by Application
  1. 5.1 Embolization Particle Application Introduction
  2. 5.1.1 Uterine Fibroid Embolization
  3. 5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  4. 5.1.3 Liver Tumor Embolization
  5. 5.1.4 Trauma Embolization
  6. 5.1.5 Others
  7. 5.2 Global Embolization Particle Sales by Application
  8. 5.2.1 Global Embolization Particle Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Embolization Particle Sales by Application (2021-2032)
  10. 5.2.3 Global Embolization Particle Sales Market Share by Application (2021-2032)
  11. 5.3 Global Embolization Particle Revenue by Application
  12. 5.3.1 Global Embolization Particle Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Embolization Particle Revenue by Application (2021-2032)
  14. 5.3.3 Global Embolization Particle Revenue Market Share by Application (2021-2032)
6 Global Embolization Particle Sales by Region
  1. 6.1 Global Embolization Particle Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Embolization Particle Sales by Region (2021-2032)
  3. 6.2.1 Global Embolization Particle Sales by Region (2021-2026)
  4. 6.2.2 Global Embolization Particle Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Embolization Particle Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Embolization Particle Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Embolization Particle Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Embolization Particle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Embolization Particle Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Embolization Particle Revenue by Region
  1. 7.1 Global Embolization Particle Revenue by Region
  2. 7.1.1 Global Embolization Particle Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Embolization Particle Revenue by Region (2021-2026)
  4. 7.1.3 Global Embolization Particle Revenue by Region (2027-2032)
  5. 7.1.4 Global Embolization Particle Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Embolization Particle Revenue (2021-2032)
  8. 7.2.2 North America Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Embolization Particle Revenue (2021-2032)
  11. 7.3.2 Europe Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Embolization Particle Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Embolization Particle Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Embolization Particle Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sirtex Medical
  2. 8.1.1 Sirtex Medical Company Information
  3. 8.1.2 Sirtex Medical Business Overview
  4. 8.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sirtex Medical Embolization Particle Product Portfolio
  6. 8.1.5 Sirtex Medical Recent Developments
  7. 8.2 Merit Medical
  8. 8.2.1 Merit Medical Company Information
  9. 8.2.2 Merit Medical Business Overview
  10. 8.2.3 Merit Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merit Medical Embolization Particle Product Portfolio
  12. 8.2.5 Merit Medical Recent Developments
  13. 8.3 Cook Medical
  14. 8.3.1 Cook Medical Company Information
  15. 8.3.2 Cook Medical Business Overview
  16. 8.3.3 Cook Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cook Medical Embolization Particle Product Portfolio
  18. 8.3.5 Cook Medical Recent Developments
  19. 8.4 BTG Medical
  20. 8.4.1 BTG Medical Company Information
  21. 8.4.2 BTG Medical Business Overview
  22. 8.4.3 BTG Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BTG Medical Embolization Particle Product Portfolio
  24. 8.4.5 BTG Medical Recent Developments
  25. 8.5 Boston Scientific Corporation
  26. 8.5.1 Boston Scientific Corporation Company Information
  27. 8.5.2 Boston Scientific Corporation Business Overview
  28. 8.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
  30. 8.5.5 Boston Scientific Corporation Recent Developments
  31. 8.6 Terumo Corporation
  32. 8.6.1 Terumo Corporation Company Information
  33. 8.6.2 Terumo Corporation Business Overview
  34. 8.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Corporation Embolization Particle Product Portfolio
  36. 8.6.5 Terumo Corporation Recent Developments
  37. 8.7 HENGRUI Medical
  38. 8.7.1 HENGRUI Medical Company Information
  39. 8.7.2 HENGRUI Medical Business Overview
  40. 8.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HENGRUI Medical Embolization Particle Product Portfolio
  42. 8.7.5 HENGRUI Medical Recent Developments
  43. 8.8 INterface BIOmaterials B.V.
  44. 8.8.1 INterface BIOmaterials B.V. Company Information
  45. 8.8.2 INterface BIOmaterials B.V. Business Overview
  46. 8.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
  48. 8.8.5 INterface BIOmaterials B.V. Recent Developments
  49. 8.9 Alicon
  50. 8.9.1 Alicon Company Information
  51. 8.9.2 Alicon Business Overview
  52. 8.9.3 Alicon Embolization Particle Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alicon Embolization Particle Product Portfolio
  54. 8.9.5 Alicon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Embolization Particle Value Chain Analysis
  2. 9.1.1 Embolization Particle Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Embolization Particle Production Mode & Process
  6. 9.2 Embolization Particle Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Embolization Particle Distributors
  9. 9.2.3 Embolization Particle Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst